Supernus Pharmaceuticals (SUPN) has a market capitalization of $2.4B, based on 58.22M shares at a price of $41.97 (down 1.6% yesterday).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
October 2026 | $42.01 | 7,209,745 | 58,224,144 | $2,445,996,289.44 |
September 2026 | $43.04 | 13,368,300 | 58,070,000 | $2,499,332,800.00 |
August 2026 | $44.21 | 21,343,620 | 58,070,000 | $2,567,274,700.00 |
July 2026 | $44.63 | 15,775,200 | 58,070,000 | $2,591,664,100.00 |
June 2026 | $46.51 | 17,072,300 | 58,070,000 | $2,700,835,700.00 |
May 2026 | $46.18 | 15,206,800 | 58,070,000 | $2,681,672,600.00 |
April 2026 | $48.00 | 11,299,700 | 58,070,000 | $2,787,360,000.00 |
March 2026 | $51.69 | 13,863,709 | 57,647,500 | $2,979,799,275.00 |
February 2026 | $54.73 | 17,595,730 | 57,647,500 | $3,155,047,675.00 |
January 2026 | $48.16 | 13,607,513 | 57,647,500 | $2,776,303,600.00 |
December 2025 | $49.70 | 13,531,878 | 57,344,000 | $2,849,996,800.00 |
November 2025 | $45.59 | 20,996,913 | 57,344,000 | $2,614,312,960.00 |
October 2025 | $55.13 | 18,298,227 | 57,344,000 | $3,161,374,720.00 |
September 2025 | $47.79 | 14,482,703 | 56,552,700 | $2,702,653,533.00 |
August 2025 | $45.12 | 20,723,372 | 56,552,700 | $2,551,657,824.00 |
July 2025 | $35.10 | 16,651,050 | 56,552,700 | $1,984,999,770.00 |
June 2025 | $31.52 | 13,443,008 | 56,643,200 | $1,785,393,664.00 |
May 2025 | $31.70 | 9,699,225 | 56,643,200 | $1,795,589,440.00 |
April 2025 | $32.48 | 11,233,908 | 56,643,200 | $1,839,771,136.00 |
March 2025 | $32.75 | 14,414,757 | 55,864,700 | $1,829,568,925.00 |
February 2025 | $32.06 | 12,764,372 | 55,864,700 | $1,791,022,282.00 |
January 2025 | $38.37 | 6,565,093 | 55,864,700 | $2,143,528,539.00 |
December 2024 | $36.16 | 7,544,590 | 56,464,800 | $2,041,767,168.00 |
November 2024 | $36.57 | 8,440,752 | 56,464,800 | $2,064,917,736.00 |
October 2024 | $34.07 | 6,303,982 | 56,464,800 | $1,923,755,736.00 |